Current state of type 1 diabetes treatment in the U.S.: Updated data from the t1d exchange clinic registry

Diabetes Care

Volumn 38, Issue 6, 2015, Pages 971-978

  Miller, Kellee M ^a   Foster, Nicole C ^a   Beck, Roy W ^a   Bergensta, Richard M ^b   DuBose, Stephanie N ^a   DiMeglio, Linda A ^c   Maahs, David M ^d   Tamborlane, William V ^e  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b INTERNATIONAL DIABETES CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN; PRAMLINTIDE; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA DERIVATIVE; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC KETOACIDOSIS; DISEASE REGISTRY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; POPULATION RESEARCH; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; COMORBIDITY; DIABETES MELLITUS, TYPE 1; HEALTH SERVICE; INSULIN INFUSION; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; REGISTER; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HEALTH SERVICES NEEDS AND DEMAND; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 84942755473     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0078     Document Type: Article

References (23)

1. NathanDM; DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 2014;37:9-16.
2. Orchard TJ, Nathan DM, Zinman B, et al.; Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015;313:45-53.
3. American Diabetes Association. (11) Children and adolescents. Diabetes Care 2015;38 (Suppl.):S70-S76.
4. Rewers MJ, Pillay K, de Beaufort C, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2014;15(Suppl. 20):102-114.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
6. Campbell MS, Schatz DA, Chen V, et al.; T1D Exchange Clinic Network. A contrast between children and adolescents with excellent and poor control: The T1D Exchange clinic registry experience. Pediatr Diabetes 2014;15:110- 117.
7. Simmons JH, Chen V, Miller KM, et al.; T1D Exchange Clinic Network. Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange clinic registry. Diabetes Care 2013;36:3573-3577.
8. Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange clinic registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013;36:2035-2037.
9. Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, et al. Evidence of a strong association between frequency of selfmonitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants. Diabetes Care 2013;36:2009-2014.
10. Blackman SM, Raghinaru D, Adi S, et al. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes 2014;15:564-572.
11. Cengiz E, Xing D, Wong JC, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 2013;14:447-454.
12. Weinstock RS, Xing D, Maahs DM, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 2013;98:3411-3419.
13. Wong JC, Foster NC, Maahs DM, et al.; T1D Exchange Clinic Network. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care 2014;37:2702-2709.
14. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network. The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97:4383-4389.
15. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-188.
16. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569.
17. Willi SM, Miller KM, DiMeglio LA, et al.; for the T1D Exchange Clinic Network. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics 2015;135:424-434.
18. Pedersen-Bjergaard U, Kristensen PL, Beck- Nielsen H, et al. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. Lancet Diabetes Endocrinol 2014;2:553-561.
19. Bergenstal RM, Tamborlane WV, Ahmann A, et al.; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
20. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359: 1464-1476.
21. Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia 2010;53:809-820.
22. Libman IM, Miller KM, Dimeglio LA, et al. Metformin as an adjunct therapy does not improve glycemic control among overweight adolescents with type 1 diabetes (T1D). Presented at the 97th Annual Meeting of the Endocrine Society, 5-8 March 2015, San Diego, CA.
23. Liese AD, D'Agostino RB Jr, Hamman RF, et al.; SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510-1518.